---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-001244"
form_type: "8-K"
ticker: "PRME"
cik: "0001894562"
company_name: "Prime Medicine, Inc."
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T03:59:09.196825+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Prime Medicine posts updated corporate presentation; details not fully disclosed in filing

## Summary
- Presentation posted Jan 13, 2025 on company website; included as exhibit but content truncated.
- No specific financial or program updates visible in provided filing text.
- Presentation titled 'Delivering on the promise of Prime Editing' suggests continued focus on gene editing platform.
- Further details may be available on investor relations page.

## SEC filing metadata
- accession: 0001628280-25-001244
- form_type: 8-K
- ticker: PRME
- cik: 0001894562
- company_name: Prime Medicine, Inc.
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1894562/000162828025001244/0001628280-25-001244-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1894562/000162828025001244/prme-20250113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-001244
- JSON: https://secwatch.observer/filing/0001628280-25-001244.json
- Plain text: https://secwatch.observer/filing/0001628280-25-001244.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.